25 May 2013
Keywords: Watson, Exelon, Seasonique, Kadian, Duramed, Actavis
Article | 13 November 2011
There was an active day for US generics drugmaker Watson Pharmaceuticals (NYSE: WPI), first, confirming that its subsidiary, Watson Laboratories, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 November 2011
14 November 2011
24 May 2013
© 2013 thepharmaletter.com